These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9649223)
21. Making Sense of Autoantibodies in Cholestatic Liver Diseases. Marzorati S; Invernizzi P; Lleo A Clin Liver Dis; 2016 Feb; 20(1):33-46. PubMed ID: 26593289 [TBL] [Abstract][Full Text] [Related]
22. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039 [TBL] [Abstract][Full Text] [Related]
23. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Sakamaki S; Takayanagi N; Yoshizaki N; Hayashi S; Takayama T; Kato J; Kogawa K; Yamauchi N; Takemoto N; Nobuoka A; Ayabe T; Kohgo Y; Niitsu Y Gut; 2000 Aug; 47(2):236-41. PubMed ID: 10896915 [TBL] [Abstract][Full Text] [Related]
26. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques. Bansi DS; Bauducci M; Bergqvist A; Boberg K; Broome U; Chapman R; Fleming K; Jorgensen R; Lindor K; Rosina F; Schrumpf E Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):575-80. PubMed ID: 9222729 [TBL] [Abstract][Full Text] [Related]
27. Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis. Yoshida H; Shiokawa M; Kuwada T; Muramoto Y; Ota S; Nishikawa Y; Maeda H; Kakiuchi N; Okamoto K; Yamazaki H; Yokode M; Nakamura T; Matsumoto S; Hirano T; Okada H; Marui S; Sogabe Y; Matsumori T; Mima A; Uza N; Eso Y; Takai A; Takahashi K; Ueda Y; Kodama Y; Chiba T; Seno H J Gastroenterol; 2023 Aug; 58(8):778-789. PubMed ID: 37310456 [TBL] [Abstract][Full Text] [Related]
28. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Saulot V; Vittecoq O; Charlionet R; Fardellone P; Lange C; Marvin L; Machour N; Le Loët X; Gilbert D; Tron F Arthritis Rheum; 2002 May; 46(5):1196-201. PubMed ID: 12115223 [TBL] [Abstract][Full Text] [Related]
29. Anti-neutrophil antibodies in primary sclerosing cholangitis. Terjung B; Worman HJ Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):629-42. PubMed ID: 11492972 [TBL] [Abstract][Full Text] [Related]
30. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. Akisawa N; Maeda T; Iwasaki S; Onishi S J Hepatol; 1997 Apr; 26(4):845-51. PubMed ID: 9126798 [TBL] [Abstract][Full Text] [Related]
31. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072 [TBL] [Abstract][Full Text] [Related]
32. Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance. Preuss B; Berg C; Altenberend F; Gregor M; Stevanovic S; Klein R Clin Exp Immunol; 2007 Nov; 150(2):312-21. PubMed ID: 17711488 [TBL] [Abstract][Full Text] [Related]
33. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442 [TBL] [Abstract][Full Text] [Related]
34. Enolase autoantibodies and retinal function in multiple sclerosis patients. Forooghian F; Adamus G; Sproule M; Westall C; O'Connor P Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1077-84. PubMed ID: 17219105 [TBL] [Abstract][Full Text] [Related]
35. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease. Shearn CT; Orlicky DJ; Petersen DR Exp Mol Pathol; 2018 Feb; 104(1):1-8. PubMed ID: 29180269 [TBL] [Abstract][Full Text] [Related]
36. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Maruyama I; Ohguro H; Ikeda Y Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1657-65. PubMed ID: 10845582 [TBL] [Abstract][Full Text] [Related]
37. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616 [TBL] [Abstract][Full Text] [Related]
38. [Primary sclerosing cholangitis (PSC)--humoral immune phenomena, pathogenetic aspects and therapeutic possibilities]. Hopf U; Stemerowicz R; Knigge O; Khadar R; König V; Lobeck H; Neuhaus P Z Gastroenterol; 1993 Feb; 31 Suppl 2():106-10. PubMed ID: 7483687 [TBL] [Abstract][Full Text] [Related]